Business Description
![Prestige Consumer Healthcare Inc Prestige Consumer Healthcare Inc logo](https://static.gurufocus.com/logos/0C000008KY.png?14)
Prestige Consumer Healthcare Inc
NAICS : 325412
SIC : 2834
ISIN : US74112D1019
Description
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 3.07 | |||||
Interest Coverage | 5.26 | |||||
Piotroski F-Score | 8/9 | |||||
Altman Z-Score | 2.66 | |||||
Beneish M-Score | -2.43 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.4 | |||||
3-Year EBITDA Growth Rate | 6 | |||||
3-Year EPS without NRI Growth Rate | 6.5 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | 6.9 | |||||
Future 3-5Y EPS without NRI Growth Rate | 4.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 1.81 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 88.65 | |||||
9-Day RSI | 75.09 | |||||
14-Day RSI | 67.31 | |||||
6-1 Month Momentum % | 1 | |||||
12-1 Month Momentum % | 17.35 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.23 | |||||
Quick Ratio | 1.9 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 113.09 | |||||
Days Sales Outstanding | 55.57 | |||||
Days Payable | 32.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 6.91 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 55.32 | |||||
Operating Margin % | 29.58 | |||||
Net Margin % | 18.43 | |||||
FCF Margin % | 22.13 | |||||
ROE % | 12.9 | |||||
ROA % | 6.16 | |||||
ROIC % | 8.03 | |||||
ROC (Joel Greenblatt) % | 109.42 | |||||
ROCE % | 10.25 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.71 | |||||
Forward PE Ratio | 16.38 | |||||
PE Ratio without NRI | 17.54 | |||||
Shiller PE Ratio | 25.51 | |||||
Price-to-Owner-Earnings | 16.6 | |||||
PS Ratio | 3.29 | |||||
PB Ratio | 2.14 | |||||
Price-to-Free-Cash-Flow | 14.77 | |||||
Price-to-Operating-Cash-Flow | 14.27 | |||||
EV-to-EBIT | 14.08 | |||||
EV-to-Forward-EBIT | 13.59 | |||||
EV-to-EBITDA | 12.85 | |||||
EV-to-Forward-EBITDA | 12.7 | |||||
EV-to-Revenue | 4.15 | |||||
EV-to-Forward-Revenue | 4.07 | |||||
EV-to-FCF | 18.77 | |||||
Price-to-Projected-FCF | 1.07 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Earnings Yield (Greenblatt) % | 7.1 | |||||
FCF Yield % | 6.86 | |||||
Forward Rate of Return (Yacktman) % | -21.41 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:PBH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Prestige Consumer Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,113.19 | ||
EPS (TTM) ($) | 4.09 | ||
Beta | 0.48 | ||
Volatility % | 24.11 | ||
14-Day RSI | 67.31 | ||
14-Day ATR ($) | 1.46017 | ||
20-Day SMA ($) | 69.0075 | ||
12-1 Month Momentum % | 17.35 | ||
52-Week Range ($) | 56.344 - 75.31 | ||
Shares Outstanding (Mil) | 49.56 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 8 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Prestige Consumer Healthcare Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Prestige Consumer Healthcare Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Prestige Consumer Healthcare Inc Frequently Asked Questions
What is Prestige Consumer Healthcare Inc(PBH)'s stock price today?
The current price of PBH is $72.44. The 52 week high of PBH is $75.31 and 52 week low is $56.34.
When is next earnings date of Prestige Consumer Healthcare Inc(PBH)?
The next earnings date of Prestige Consumer Healthcare Inc(PBH) is 2024-11-01 Est..
Does Prestige Consumer Healthcare Inc(PBH) pay dividends? If so, how much?
Prestige Consumer Healthcare Inc(PBH) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |